Abstract
Resveratrol is a phenolic compound that has been widely studied in the last years because of its extensive pharmacological properties. It also has physicochemical properties that are adequate for diffusion through the human skin. An analytical method by high performance liquid chromatography was developed and validated for its determination in transdermal emulsion, as well in receptor media and skin layers. The trans-resveratrol release kinetic followed the Higushi’s model (R2 = 0.9926) with steady-state diffusion flux and lag time of 138.5 µg cm–2 h–1 and 0.49 h, respectively. It showed a percentage at 64.96 % for permeation. Thus, the results suggest that the emulsion studied is a potential vehicle for transresveratrol administration by transdermal route.
Keywords: Ex vivo human skin permeation, high performance liquid chromatography, in vitro drug release, resveratrol, transdermal emulsion, validation studies.
Graphical Abstract
Current Drug Delivery
Title:Studies with Emulsion Containing trans-resveratrol: in vitro Release Profile and ex vivo Human Skin Permeation
Volume: 12 Issue: 2
Author(s): Priscila Aparecida de Almeida, Michele Campos Alves, Hudson Caetano Polonini, Stephane Lima Calixto, Tiago Brum Braga Gomes, Alexandre Augusto Barros Lataliza, Cristiano Dias da Silveira Ramos, Nadia Rezende Barbosa Raposo, Anderson de Oliveira Ferreira and Marcos Antonio Fernandes Brandao
Affiliation:
Keywords: Ex vivo human skin permeation, high performance liquid chromatography, in vitro drug release, resveratrol, transdermal emulsion, validation studies.
Abstract: Resveratrol is a phenolic compound that has been widely studied in the last years because of its extensive pharmacological properties. It also has physicochemical properties that are adequate for diffusion through the human skin. An analytical method by high performance liquid chromatography was developed and validated for its determination in transdermal emulsion, as well in receptor media and skin layers. The trans-resveratrol release kinetic followed the Higushi’s model (R2 = 0.9926) with steady-state diffusion flux and lag time of 138.5 µg cm–2 h–1 and 0.49 h, respectively. It showed a percentage at 64.96 % for permeation. Thus, the results suggest that the emulsion studied is a potential vehicle for transresveratrol administration by transdermal route.
Export Options
About this article
Cite this article as:
de Almeida Aparecida Priscila, Alves Campos Michele, Polonini Caetano Hudson, Calixto Lima Stephane, Braga Gomes Brum Tiago, Barros Lataliza Augusto Alexandre, da Silveira Ramos Dias Cristiano, Barbosa Raposo Rezende Nadia, Oliveira Ferreira de Anderson and Fernandes Brandao Antonio Marcos, Studies with Emulsion Containing trans-resveratrol: in vitro Release Profile and ex vivo Human Skin Permeation, Current Drug Delivery 2015; 12 (2) . https://dx.doi.org/10.2174/1567201812666150130161736
DOI https://dx.doi.org/10.2174/1567201812666150130161736 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurotuberculosis: An Overview
Central Nervous System Agents in Medicinal Chemistry A Resurrection of 7-MEOTA: A Comparison with Tacrine
Current Alzheimer Research Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications
Current Cancer Drug Targets Mechanism of Action of Flavonoids as Anti-inflammatory Agents: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Imaging of Hypoxia Using PET and MRI
Current Pharmaceutical Biotechnology Mepolizumab and Eosinophil-Mediated Disease
Current Medicinal Chemistry Synthesis of Natural Products Using Intramolecular Dipolar Cycloaddition Reactions
Current Organic Synthesis Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
Current Topics in Medicinal Chemistry Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Current Neurovascular Research Anti-Angiogenic Effects of Resveratrol on Cerebral Angiogenesis
Current Neurovascular Research Lipid Based Nanosystems for Curcumin: Past, Present and Future
Current Pharmaceutical Design On the Role of Neuropeptides in the Hypothalamic Regulation of Food Intake
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Recent Progress of Src Family Kinase Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Exploring Novel Approaches to Vaginal Drug Delivery
Recent Patents on Drug Delivery & Formulation Snake Venom Induced Local Toxicities: Plant Secondary Metabolites as an Auxiliary Therapy
Mini-Reviews in Medicinal Chemistry Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine), Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl- L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Recent Patents on Drug Delivery & Formulation Metabolic Targets of Cardiac HormonesTherapeutic Anti-Cancer Effects
Current Pharmaceutical Design 2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth
Anti-Cancer Agents in Medicinal Chemistry Oxidative Stress and Mitochondrial Impairment After Treatment with Anti-HIV Drugs: Clinical Implications
Current Pharmaceutical Design